.Molecular Companions has recognized "suboptimal exposure" to its tetra-specific T-cell engager as t...
.While the biotech financial investment performance in Europe has slowed down relatively adhering to...
.After increasing $213 million in 2023-- some of the year's largest private biotech rounds-- Volume ...
.Invite to this week's Chutes & Ladders, our roundup of significant management hirings, firings a...
.Venture capital financing in to biopharma cheered $9.2 billion throughout 215 sell the second fourt...
.Bicara Therapeutics and also Zenas Biopharma have provided fresh motivation to the IPO market along...
.Genentech is going to shut its cancer cells immunology study division, as well as system mind and a...
.Kezar Lifestyle Sciences is dropping its unpromising period 1 strong tumor medication as the biotec...
.Even with izokibep keeping its own newfound winning streak in the center, Acelyrin is actually no m...
.Rivus Pharmaceuticals has plumped up the potential customers of its own fat-busting, muscle-sparing...